BlackRock’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.3M Buy
441,975
+11,893
+3% +$814K ﹤0.01% 3048
2025
Q4
$29.9M Buy
430,082
+166,144
+63% +$6.78M ﹤0.01% 2845
2025
Q3
$7.39M Buy
263,938
+20,604
+8% +$410K ﹤0.01% 3606
2025
Q2
$5.05M Sell
243,334
-323,171
-57% -$7.11M ﹤0.01% 3771
2025
Q1
$9.81M Sell
566,505
-44,080
-7% -$1.08M ﹤0.01% 3331
2024
Q4
$16.6M Sell
610,585
-69,512
-10% -$2.47M ﹤0.01% 3159
2024
Q3
$29.8M Sell
680,097
-262,922
-28% -$10.2M ﹤0.01% 2788
2024
Q2
$37M Sell
943,019
-143,394
-13% -$5.89M ﹤0.01% 2590
2024
Q1
$46.6M Buy
1,086,413
+25,355
+2% +$1.07M ﹤0.01% 2471
2023
Q4
$43.2M Buy
1,061,058
+533,728
+101% +$30.6M ﹤0.01% 2560
2023
Q3
$26.6M Buy
527,330
+132,484
+34% +$4.27M ﹤0.01% 2776
2023
Q2
$16.4M Sell
394,846
-5,154
-1% -$144K ﹤0.01% 3152
2023
Q1
$9.52M Buy
+400,000
New +$9.4M ﹤0.01% 3343

Other funds holding GPCR